ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Bausch Health Companies Inc

Bausch Health Companies Inc (BHC)

11.17
-0.28
(-2.45%)
終了 11月24日 6:12AM

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
11.17
買値
11.14
売値
11.19
出来高
193,293
11.14 日の範囲 11.45
5.45 52 週間の範囲 15.43
時価総額
前日終値
11.45
始値
11.39
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
356,321
発行済株式数
365,239,000
配当利回り
-
PER
-6.88
1 株当たり利益 (EPS)
-1.62
歳入
8.76B
純利益
-592M

Bausch Health Companies Inc について

セクター
Pharmaceutical Preparations
業界
Drugs
ウェブサイト
本社
Quebec City, Quebec, Can
設立
1994
Bausch Health Companies Inc is listed in the Pharmaceutical Preparations sector of the トロント証券取引所 with ticker BHC. The last closing price for Bausch Health Companies was $11.45. Over the last year, Bausch Health Companies shares have traded in a share price range of $ 5.45 to $ 15.43.

Bausch Health Companies currently has 365,239,000 shares in issue. The market capitalisation of Bausch Health Companies is $4.18 billion. Bausch Health Companies has a price to earnings ratio (PE ratio) of -6.88.

BHC 最新ニュース

OraPharma and Alex Rodriguez Team Up to Raise Awareness About the Importance of Managing Gum Disease

OraPharma and Alex Rodriguez Team Up to Raise Awareness About the Importance of Managing Gum Disease PR Newswire LAVAL, QC, May 31, 2023 Cover Your Bases Campaign Kicks Off Oral Health Month with...

SALIX PHARMACEUTICALS RELEASES LIVER HEALTH ANNUAL TRENDS REPORT UNDERSCORING CHALLENGES IN CARING FOR GROWING CHRONIC LIVER DISEASE AND CIRRHOTIC PATIENT POPULATION

SALIX PHARMACEUTICALS RELEASES LIVER HEALTH ANNUAL TRENDS REPORT UNDERSCORING CHALLENGES IN CARING FOR GROWING CHRONIC LIVER DISEASE AND CIRRHOTIC PATIENT POPULATION PR Newswire LAVAL, QC, Oct...

Seasonal Affective Disorder (SAD) Is Now a Recognized Diagnosis in the CMS Tabular Index, Accessible to Prescribers Oct. 1, 2022

Seasonal Affective Disorder (SAD) Is Now a Recognized Diagnosis in the CMS Tabular Index, Accessible to Prescribers Oct. 1, 2022 PR Newswire LAVAL, QC, Oct. 5, 2022 CMS Issues New Clarification...

SALIX PHARMACEUTICALS APPLAUDS IMPLEMENTATION OF K76.82 - A NEW ICD-10 CODE FOR HEPATIC ENCEPHALOPATHY

SALIX PHARMACEUTICALS APPLAUDS IMPLEMENTATION OF K76.82 - A NEW ICD-10 CODE FOR HEPATIC ENCEPHALOPATHY PR Newswire LAVAL, QC, Oct. 3, 2022 Centers for Medicare & Medicaid Services (CMS...

Bausch Health Announces Final Results and Expiration of Exchange Offers and Consent Solicitations

Bausch Health Announces Final Results and Expiration of Exchange Offers and Consent Solicitations PR Newswire LAVAL, Quebec, Sept. 28, 2022 LAVAL, Quebec, Sept. 28, 2022 /PRNewswire/ -- Bausch...

Bausch Health Announces Early Exchange Offer Results for Exchange Offers and Consent Solicitations

Bausch Health Announces Early Exchange Offer Results for Exchange Offers and Consent Solicitations PR Newswire LAVAL, QC, Sept. 14, 2022 LAVAL, QC, Sept. 14, 2022 /PRNewswire/ -- Bausch Health...

Bausch Health Responds to Norwich Pharmaceuticals Tentative FDA Approval for a 200 mg Rifaximin

Bausch Health Responds to Norwich Pharmaceuticals Tentative FDA Approval for a 200 mg Rifaximin PR Newswire LAVAL, QC, Sept. 9, 2022 LAVAL, QC, Sept. 9, 2022 /PRNewswire/ -- Bausch Health...

Bausch Health Clarifies Release Provisions Related to its Exchange Offers and Consent Solicitations

Bausch Health Clarifies Release Provisions Related to its Exchange Offers and Consent Solicitations PR Newswire LAVAL, Quebec, Sept. 8, 2022 LAVAL, Quebec, Sept. 8, 2022 /PRNewswire/ -- Bausch...

Bausch Health Announces Exchange Offers and Consent Solicitations for Certain Existing Senior Notes with Support from Approximately 23% of Outstanding Existing Senior Notes

Bausch Health Announces Exchange Offers and Consent Solicitations for Certain Existing Senior Notes with Support from Approximately 23% of Outstanding Existing Senior Notes PR Newswire LAVAL...

Bausch Health Continuing Process Toward Separating Bausch + Lomb

Bausch Health Continuing Process Toward Separating Bausch + Lomb PR Newswire LAVAL, QC, Aug. 22, 2022 LAVAL, QC, Aug. 22, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-1.1-8.9649551752212.2712.2711.1417477911.63946991CS
4-0.1-0.88731144631811.2713.7411.130862512.67415461CS
123.2641.2136536037.9113.747.935632111.10702761CS
262.2625.36475869818.9113.745.453750489.69948279CS
521.6517.33193277319.5215.435.4536138410.56089226CS
156-21.84-66.161769160933.0136.265.165063212.63177295CS
260-25.56-69.58889191436.7343.975.163903319.4736968CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
AABAberdeen International Inc
$ 0.065
(18.18%)
226.54k
MDPMedexus Pharmaceuticals Inc
$ 2.45
(15.02%)
46.31k
NCFNorthcliff Resources Ltd
$ 0.04
(14.29%)
5k
SAMStarcore International Mines Ltd
$ 0.16
(14.29%)
200k
GECGlobal Education Communities Corp
$ 0.225
(12.50%)
60k
BNGBengal Energy Ltd
$ 0.005
(-50.00%)
20k
RTGRTG Mining Inc
$ 0.03
(-25.00%)
13k
SMCSulliden Mining Capital Inc
$ 0.015
(-25.00%)
200k
APSAptose Biosciences Inc
$ 0.27
(-20.59%)
346.55k
FLNTFlint Corporation
$ 0.025
(-16.67%)
28k
SUSuncor Energy Inc
$ 58.04
(0.94%)
14.14M
MFCManulife Financial Corporation
$ 45.42
(-0.53%)
9.73M
SLFSun Life Financial Inc
$ 85.54
(-0.23%)
6.19M
BITFBitfarms Ltd
$ 2.96
(3.14%)
6.17M
CNQCanadian Natural Resources Ltd
$ 48.70
(0.83%)
4.91M

BHC Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock